{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:47:10Z","timestamp":1794728830510,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier","isbn-type":[{"value":"9780323855389","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/b978-0-323-85538-9.00012-2","type":"book-chapter","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:49:42Z","timestamp":1676396982000},"page":"57-71","source":"Crossref","is-referenced-by-count":30,"title":["Mixed pathology as a rule, not exception: Time to reconsider disease nosology"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","article-title":"The epidemiology of dementia associated with Parkinson's disease","volume":"20","author":"Aarsland","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0025","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/archneur.63.12.1763","article-title":"Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease","volume":"63","author":"Aggarwal","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurosci Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0040","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fncel.2015.00423","article-title":"Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS?","volume":"9","author":"Aulas","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026609","article-title":"Tau enhances \u03b1-synuclein aggregation and toxicity in cellular models of synucleinopathy","volume":"6","author":"Badiola","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0060","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of \u03b1-synuclein in Parkinson's disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"J Brain Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0070","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1038\/srep15410","article-title":"A\u03b242-oligomer interacting peptide (AIP) neutralizes toxic amyloid-\u03b242 species and protects synaptic structure and function","volume":"5","author":"Barucker","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1213\/ANE.0000000000004069","article-title":"Glymphatic system function in relation to anesthesia and sleep states","volume":"128","author":"Benveniste","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0095","doi-asserted-by":"crossref","first-page":"e1821","DOI":"10.1212\/WNL.0000000000007315","article-title":"Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies","volume":"92","author":"Buchman","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/gerona\/glaa176","article-title":"Person-specific contributions of brain pathologies to progressive Parkinsonism in older adults","volume":"76","author":"Buchman","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb9216","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/ja5131726","article-title":"Elucidating the role of site-specific nitration of \u03b1-synuclein in the pathogenesis of Parkinson's disease via protein semisynthesis and mutagenesis","volume":"137","author":"Burai","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","article-title":"Dementia and survival in Parkinson disease: a 12-year population study","volume":"70","author":"Buter","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1073\/pnas.1914017117","article-title":"Imaging the effect of the circadian light\u2013dark cycle on the glymphatic system in awake rats","volume":"117","author":"Cai","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1074\/jbc.M116.737726","article-title":"Quantification of the relative contributions of loss-of-function and gain-of-function mechanisms in TAR DNA-binding protein 43 (TDP-43) proteinopathies","volume":"291","author":"Cascella","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.abb.2013.02.009","article-title":"Oxidation and nitration of \u03b1-synuclein and their implications in neurodegenerative diseases","volume":"533","author":"Chavarr\u00eda","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0125","doi-asserted-by":"crossref","first-page":"eaam6790","DOI":"10.1126\/scisignal.aam6790","article-title":"Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease","volume":"10","author":"Chen","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.05.003","article-title":"Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease","volume":"69","author":"Chu","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11910-015-0549-x","article-title":"The prion hypothesis of Parkinson's disease","volume":"15","author":"Chu","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0140","series-title":"Increase of tau immunoreactivities in sporadic and experimental Parkinson's disease. 2016 Neuroscience abstract","author":"Chu","year":"2016"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0145","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1093\/brain\/awz296","article-title":"Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes","volume":"142","author":"Chu","year":"2019","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0150","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awx255","article-title":"Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease","volume":"140","author":"Cisbani","year":"2017","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bpa.12044","article-title":"\u201cPrion-like\u201d templated misfolding in tauopathies","volume":"23","author":"Clavaguera","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024372","article-title":"The prion-like behavior of assembled tau in transgenic mice","volume":"7","author":"Clavaguera","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0165","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","article-title":"TDP-43 is recruited to stress granules in conditions of oxidative insult","volume":"111","author":"Colombrita","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","article-title":"The significance of \u03b1-synuclein, amyloid-\u03b2 and tau pathologies in Parkinson's disease progression and related dementia","volume":"13","author":"Compta","year":"2014","journal-title":"Neurodegener Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1742-2094-8-166","article-title":"The acute inflammatory response to intranigral \u03b1-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation","volume":"8","author":"Couch","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fncel.2017.00243","article-title":"Failure to deliver and translate-new insights into RNA dysregulation in ALS","volume":"11","author":"Coyne","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0185","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to Parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12640-009-9073-6","article-title":"Role of synucleins in Alzheimer's disease","volume":"16","author":"Crews","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0195","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12031-021-01836-4","article-title":"Decreased AQP4 expression aggravates \u0251-synuclein pathology in Parkinson's disease mice, possibly via impaired glymphatic clearance","volume":"71","author":"Cui","year":"2021","journal-title":"J Mol Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0200","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-synuclein contributes to GSK-3beta-catalyzed tau phosphorylation in Parkinson's disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","article-title":"Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology","volume":"133","author":"Dzamko","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0210","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1074\/jbc.M111.247965","article-title":"E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment","volume":"286","author":"Emmer","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0220","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0225","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.expneurol.2014.05.025","article-title":"LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis","volume":"261","author":"Esteves","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0235","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau (181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3940(02)00106-4","article-title":"The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population","volume":"322","author":"Farrer","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0245","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","article-title":"Mitochondria, oxidative stress and neurodegeneration","volume":"322","author":"Federico","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0255","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2004.07.016","article-title":"Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein","volume":"192","author":"Frasier","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0260","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0265","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0891988716654985","article-title":"Parkinson disease and dementia","volume":"29","author":"Garcia-Ptacek","year":"2016","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect \u03b1-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease","volume":"14","author":"George","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-018-0245-9","article-title":"Tau oligomers mediate \u03b1-synuclein toxicity and can be targeted by immunotherapy","volume":"13","author":"Gerson","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0285","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0290","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0959-4388(98)80090-1","article-title":"Filamentous nerve cell inclusions in neurodegenerative diseases","volume":"8","author":"Goedert","year":"1998","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0300","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0305","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2018.11.015","article-title":"P\u03b1-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria","volume":"124","author":"Grassi","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0310","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson's disease dementia: a neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0315","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1007\/s12035-015-9209-z","article-title":"LRRK2 promotes tau accumulation, aggregation and release","volume":"53","author":"Guerreiro","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0325","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","article-title":"Hyperphosphorylated Tau in an \u03b1-synuclein-overexpressing transgenic model of Parkinson's disease","volume":"33","author":"Haggerty","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF biomarkers and clinical progression of Parkinson disease","volume":"84","author":"Hall","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0335","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","article-title":"Striatal \u03b2-amyloid in dementia with Lewy bodies but not Parkinson's disease","volume":"118","author":"Halliday","year":"2011","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0340","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/brain\/awm065","article-title":"TDP-43 is deposited in the Guam parkinsonism-dementia complex brains","volume":"130","author":"Hasegawa","year":"2007","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0345","article-title":"Intranasal LPS-mediated Parkinson's model challenges the pathogenesis of nasal cavity and environmental toxins","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0350","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134316","article-title":"\u03b1-Synuclein pathology in Parkinson's disease and related \u03b1-synucleinopathies","volume":"709","author":"Henderson","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","article-title":"Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease","volume":"7","author":"Henderson","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0365","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-\u03b2 pathology in Parkinson disease and dementia with Lewy bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0370","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40266-018-00636-7","article-title":"Pharmacological management of dementia with Lewy bodies","volume":"36","author":"Hershey","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0375","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1038\/s41598-019-48790-1","article-title":"Dynamical decoration of stabilized-microtubules by Tau-proteins","volume":"9","author":"Hervy","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0380","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0385","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0390","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162717","article-title":"Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant","volume":"11","author":"Hoenen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0400","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bpa.12369","article-title":"Expression of aquaporin 1 and aquaporin 4 in the temporal neocortex of patients with Parkinson's disease","volume":"27","author":"Hoshi","year":"2017","journal-title":"Brain Pathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0405","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0410","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0415","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4172\/2161-0460.1000444","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0420","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI200317638","article-title":"Oxidative stress and nitration in neurodegeneration: cause, effect, or association?","volume":"111","author":"Ischiropoulos","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0425","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","article-title":"Colocalization of tau and alpha-synuclein epitopes in Lewy bodies","volume":"62","author":"Ishizawa","year":"2003","journal-title":"Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0430","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: a beginner's guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0435","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-003-0751-9","article-title":"Age-associated prevalence and risk factors of Lewy body pathology in a general population","volume":"106","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","article-title":"Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?","volume":"112","author":"Jellinger","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00401-006-0156-7","article-title":"Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease","volume":"113","author":"Jellinger","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0450","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0455","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e31816362aa","article-title":"Striatal beta-amyloid deposition in Parkinson disease with dementia","volume":"67","author":"Kalaitzakis","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0460","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2010.10.005","article-title":"Striatal A\u03b2 peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes","volume":"41","author":"Kalaitzakis","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0465","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2202-12-79","article-title":"Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease","volume":"12","author":"Kaul","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0470","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1111\/j.1742-4658.2011.08389.x","article-title":"Stimulatory effect of \u03b1-synuclein on the tau-phosphorylation by GSK-3\u03b2","volume":"278","author":"Kawakami","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0475","article-title":"The role of \u03b1-synuclein and LRRK2 in tau phosphorylation","volume":"2015","author":"Kawakami","year":"2015","journal-title":"Parkinsons Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0480","first-page":"248","article-title":"Molecular mechanisms of LRRK2-mediated abnormal phosphorylation of Tau protein","volume":"88","author":"Kawakami","year":"2016","journal-title":"Seikagaku"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0485","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0490","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease","volume":"29","author":"Kelly","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.6","article-title":"\u03b21-integrin-dependent migration of microglia in response to neuron-released \u03b1-synuclein","volume":"46","author":"Kim","year":"2014","journal-title":"Exp Mol Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0500","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","article-title":"Non-cell-autonomous neurotoxicity of \u03b1-synuclein through microglial toll-like receptor 2","volume":"25","author":"Kim","year":"2016","journal-title":"Exp Neurobiol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0505","first-page":"P28","article-title":"Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer's disease","volume":"52B","author":"Kluger","year":"1997","journal-title":"Psychol Sci Soc Sci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0510","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ana.24820","article-title":"Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient","volume":"81","author":"Kordower","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0515","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of \u03b1-synuclein and A\u03b2 in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0520","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0525","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1471-4914(01)02246-8","article-title":"Alzheimer's and Parkinson's disease\u2014overlapping or synergistic pathologies?","volume":"8","author":"Kurosinski","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0530","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.10826","article-title":"Tau haplotypes regulate transcription and are associated with Parkinson's disease","volume":"55","author":"Kwok","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0535","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0540","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4049\/jimmunol.0903480","article-title":"Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1","volume":"185","author":"Lee","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0545","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-020-73151-8","article-title":"Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer's disease model","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0550","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2006.01.010","article-title":"Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally","volume":"199","author":"Ling","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0555","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0560","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0565","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2019.01.048","article-title":"RNA binding antagonizes neurotoxic phase transitions of TDP-43","volume":"102","author":"Mann","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0570","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb9215","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","article-title":"Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates","volume":"26","author":"Mazzulli","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0575","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fneur.2019.00391","article-title":"Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease","volume":"10","author":"Melzer","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0580","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrn3380","article-title":"Axonal transport deficits and neurodegenerative diseases","volume":"14","author":"Millecamps","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0585","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/molecules23092142","article-title":"Characterization of the structure and oligomerisation of islet amyloid polypeptides (IAPP): a review of molecular dynamics simulation studies","volume":"23","author":"Moore","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0590","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0595","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1789.2010.01159.x","article-title":"Tau-positive glial cytoplasmic granules in multiple system atrophy","volume":"31","author":"Nagaishi","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0600","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Nakashima-Yasuda","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0605","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0610","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/bs.irn.2017.05.002","article-title":"Cognition in Parkinson's disease","volume":"133","author":"O\u2019Callaghan","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0615","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/brain\/awz104","article-title":"Temporal evolution of microglia and \u03b1-synuclein accumulation following foetal grafting in Parkinson's disease","volume":"142","author":"Olanow","year":"2019","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0620","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2019.12.013","article-title":"Co-existence of tau and \u03b1-synuclein pathology in fetal graft tissue at autopsy: a case report","volume":"71","author":"Ornelas","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0625","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Pais\u00e1n-Ru\u00edz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0630","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1038\/s41586-020-2790-y","article-title":"A protein assembly mediates Xist localization and gene silencing","volume":"586","author":"Pandya-Jones","year":"2020","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0635","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1523\/JNEUROSCI.0391-19.2019","article-title":"Drosophila tau negatively regulates translation and olfactory long-term memory, but facilitates footshock habituation and cytoskeletal homeostasis","volume":"39","author":"Papanikolopoulou","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0640","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2014.07.012","article-title":"Evidence for lymphatic A\u03b2 clearance in Alzheimer's transgenic mice","volume":"71","author":"Pappolla","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0645","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","article-title":"A\u03b2-amyloid deposition in patients with Parkinson disease at risk for development of dementia","volume":"79","author":"Petrou","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0650","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signaling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0655","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0660","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-018-25008-4","article-title":"Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization","volume":"8","author":"Pinarbasi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0665","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0670","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jnr.21206","article-title":"Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain","volume":"85","author":"Qin","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0675","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.parkreldis.2012.11.003","article-title":"TARDBP mutations in Parkinson's disease","volume":"19","author":"Rayaprolu","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nbd.2018.03.001","article-title":"Inflammation kinase PKR phosphorylates \u03b1-synuclein and causes \u03b1-synuclein-dependent cell death","volume":"115","author":"Reimer","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0685","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","article-title":"Glymphatic system impairment in Alzheimer's disease and idiopathic normal pressure hydrocephalus","volume":"26","author":"Reeves","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0690","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0695","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11481-008-9100-z","article-title":"Nitrated alpha-synuclein and microglial neuroregulatory activities","volume":"3","author":"Reynolds","year":"2008","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0700","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0705","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0710","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0000000000003840","article-title":"Decrease in A\u03b242 predicts dopa-resistant gait progression in early Parkinson disease","volume":"88","author":"Rochester","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0715","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1074\/jbc.M114.548859","article-title":"Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A\/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43)","volume":"289","author":"Romano","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0720","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","article-title":"Immunological features of alpha-synuclein in Parkinson's disease","volume":"12","author":"Roodveldt","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0725","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0730","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0735","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.20723","article-title":"Substantia nigra tangles are related to gait impairment in older persons","volume":"59","author":"Schneider","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0740","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JPD-130301","article-title":"Sleep disorders in Parkinson's disease","volume":"4","author":"Schrempf","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0745","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/09680519050110040901","article-title":"Non-LPS targets and actions of LPS binding protein (LBP)","volume":"11","author":"Schr\u00f6der","year":"2005","journal-title":"J Endotoxin Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0750","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1021\/ja2009554","article-title":"Allostery in a disordered protein: oxidative modifications to \u03b1-synuclein act distally to regulate membrane binding","volume":"133","author":"Sevcsik","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb9214","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/acs.biochem.5b00326","article-title":"LRRK2 facilitates tau phosphorylation through strong interaction with tau and cdk5","volume":"54","author":"Shanley","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0755","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11064-005-9233-x","article-title":"Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease","volume":"31","author":"Shavali","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0760","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ng1858","article-title":"Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability","volume":"38","author":"Shaw-Smith","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0765","first-page":"693","article-title":"Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues","volume":"64","author":"Shin","year":"1991","journal-title":"Lab Invest"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0770","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0775","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","article-title":"Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of \u03b1-synucleinopathy","volume":"138","author":"Singh","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0780","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bandl.2018.08.002","article-title":"Communication impairment in Parkinson's disease: impact of motor and cognitive symptoms on speech and language","volume":"185","author":"Smith","year":"2018","journal-title":"Brain Lang"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0785","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13311-020-00966-8","article-title":"Nightmare disorder and isolated sleep paralysis","volume":"18","author":"Stefani","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0790","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"Elife"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0795","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":"Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0800","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson's disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0805","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb9213","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0810","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)02498-8","article-title":"Tyrosine 125 of alpha-synuclein plays a critical role for dimerization following nitrative stress","volume":"938","author":"Takahashi","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0815","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082930","article-title":"General anesthetics inhibit LPS-induced IL-1\u03b2 expression in glial cells","volume":"8","author":"Tanaka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0820","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1742-2094-10-143","article-title":"Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice","volume":"10","author":"Tanaka","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0830","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0835","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/mt.2009.3","article-title":"Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression","volume":"17","author":"Tatom","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0840","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0845","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7150\/ijbs.7.234","article-title":"TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice","volume":"7","author":"Tian","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0850","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/01.wnl.0000304051.01650.23","article-title":"Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study","volume":"71","author":"Tobin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0855","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/ars.2011.4363","article-title":"Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice","volume":"17","author":"Tokuda","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0860","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","article-title":"Characterizing the RNA targets and position-dependent splicing regulation by TDP-43","volume":"14","author":"Tollervey","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0865","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-Synuclein in the pathophysiology of Alzheimer's disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0870","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0875","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.parkreldis.2012.03.024","article-title":"LRRK2 I2020T mutation is associated with tau pathology","volume":"18","author":"Ujiie","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0880","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molbrainres.2004.11.014","article-title":"Effects of nitration on the structure and aggregation of alpha-synuclein","volume":"134","author":"Uversky","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0885","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3389\/fphar.2019.01656","article-title":"Altered waste disposal system in aging and Alzheimer's disease: focus on astrocytic aquaporin-4","volume":"10","author":"Valenza","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0890","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molmed.2013.11.003","article-title":"TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?","volume":"20","author":"Vanden Broeck","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0895","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2007.11.019","article-title":"Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease","volume":"30","author":"Vandrovcova","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0900","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","article-title":"Prion-like propagation of pathology in Parkinson disease","volume":"153","author":"Volpicelli-Daley","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0905","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0910","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"Walker","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0915","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0920","doi-asserted-by":"crossref","first-page":"eaaw3210","DOI":"10.1126\/scitranslmed.aaw3210","article-title":"An ocular glymphatic clearance system removes \u03b2-amyloid from the rodent eye","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0925","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/JIR.S301531","article-title":"LRRK2-NFATc2 pathway associated with neuroinflammation may be a potential therapeutic target for Parkinson's disease","volume":"14","author":"Wang","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0930","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0935","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fpsyt.2010.00150","article-title":"A tangled web\u2014tau and sporadic Parkinson's disease","volume":"1","author":"Wray","year":"2010","journal-title":"Front Psychiatry"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0940","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","article-title":"Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains","volume":"74","author":"Zeppenfeld","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0945","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fneur.2018.00809","article-title":"Tau pathology in Parkinson's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0950","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmedgenet-2017-105047","article-title":"Genetics of Parkinson's disease and related disorders","volume":"55","author":"Zhang","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0955","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.neuroscience.2005.06.049","article-title":"Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits","volume":"135","author":"Zhang","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0960","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0965","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1212\/WNL.0000000000008683","article-title":"Apathy rating scores and \u03b2-amyloidopathy in patients with Parkinson disease at risk for cognitive decline","volume":"94","author":"Zhou","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0970","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jnc.12010","article-title":"A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats","volume":"123","author":"Zhou","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0975","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0980","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cellimm.2005.04.019","article-title":"Expression and function of Toll-like receptor on T cells","volume":"233","author":"Xu","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0985","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2009.01.002","article-title":"Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia","volume":"9","author":"Xu","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0990","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits","volume":"10","author":"Xu","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-323-85538-9.00012-2_bb0995","article-title":"Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"}],"container-title":["Handbook of Clinical Neurology","Precision Medicine in Neurodegenerative Disorders, Part I"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323855389000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323855389000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:55:38Z","timestamp":1762073738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323855389000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323855389"],"references-count":202,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-85538-9.00012-2","relation":{},"ISSN":["0072-9752"],"issn-type":[{"value":"0072-9752","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}